Italfarmaco Provides Givinostat Update (January 2018) Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 7 years ago You may also like 1:00:21 Biglycan (December 2011) 13 years ago Research & Clinical Trial Webinars,Webinars 1:00:38 Fat Embolism Syndrome Following Mild Trauma in Duchenne (December 2011) 13 years ago Care Webinars,Webinars 59:50 Genetic Testing Webinar (November 2011) 13 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 1:01:55 Direct Access: Dr. Kathryn Wagner, Kennedy Krieger Institute (September 2011) 13 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars «1…232425Page 25 of 25
by: Parent Project Muscular Dystrophy
